National
Fla. gay Republicans hail Romney victory
Log Cabin warns of ‘anti-gay pandering’
Mitt Romney won a decisive victory in Florida this week, as Newt Gingrich appeared to lose momentum. (Blade file photo by MIchael Key)
FORT LAUDERDALE, Fla. — Gay Republicans joined many of their straight counterparts in Florida Tuesday night in congratulating former Massachusetts Gov. Mitt Romney for his decisive victory in the Florida Republican primary.
But R. Clarke Cooper, executive director of the national Log Cabin Republicans, while also congratulating Romney, cautioned him against engaging in “anti-gay pandering or divisive social politics.”
Cooper told the Blade his comment was a reference to statements Romney has made in news media interviews over the past several months in which he appeared to be appealing to conservative voters hostile to gay rights.
Officials with Log Cabin’s chapters in the Miami, Fort Lauderdale and Tampa areas said support for Romney was strong among LGBT Republicans in the state. Romney won by a lopsided margin in a Jan. 28 straw poll of Log Cabin members at an informal gay Republican caucus in Miami.
“I’m pleased that Romney won,” said Andy Eddy, board member of Log Cabin Republicans of Broward County, which includes the city of Fort Lauderdale and the nearby gay enclave Wilton Manors.
“Many of our members support him and believe he has the best chance of beating Obama,” he said.
With 100 percent of the election precincts counted, Romney captured 46 percent of the vote. His closest rival, former House Speaker Newt Gingrich received 32 percent, former Pennsylvania Sen. Rick Santorum received 13 percent, and Texas Congressman Ron Paul received 7 percent.
In Florida’s winner take all primary, Romney captured 50 delegates, giving him a boost going into a series of upcoming primaries and caucuses leading up to Super Tuesday on March 6, when 10 states hold primaries.
“This big win for Gov. Romney makes it all but certain that he will emerge as the nominee of the Republican Party,” said Jimmy LaSalvia, executive director of the gay conservative group GOProud.
“Gov. Romney’s win tonight is particularly pivotal given the size of the state and the importance Florida will have in electing the next president,” he said. “Gov. Romney’s message of economic hope and renewal has clearly resonated with the voters of Florida.
“The truth that neither Barack Obama nor his friends in the liberal media want to discuss is that most Americans, gay or straight, are no better off than they were in 2008 and that is a product of Obama’s failed big government policies,” said LaSalvia, who personally endorsed Romney earlier this month.
Cooper said Log Cabin has a longstanding rule of not endorsing presidential candidates until the time of the Republican National Convention. He said on Tuesday night that the timing of the club’s endorsement vote is strictly “administrative” in nature and has no bearing on the group’s views of Romney.
During the Log Cabin caucus in Miami on Jan. 28, which followed a national Log Cabin board meeting, Cooper and officials with Log Cabin chapters in Florida said the group’s members clearly were leaning toward backing Romney.
Hastings Wyman, editor of Southern Political Report, a newsletter specializing in reporting on politics in the South, characterized as “remarkable” Romney’s dramatic rise in popularity in Florida. He noted that Romney had been trailing Gingrich in the Sunshine State by double digits in the days following Gingrich’s win in the South Carolina primary.
“I think the biggest single factor was money,” said Wyman, in referring to Romney’s lopsided lead over Gingrich and the other three GOP contenders in money raised for his campaign.
Newt Gingrich has vowed to fight on after losing big to Mitt Romney in Florida’s primary this week. (Blade photo by Michael Key)
“I also think Romney did much better in the last two debates in Florida,” Wyman said. “Gingrich just didn’t look as strong. The performance and appearance in the debates by Romney was much better.”
Wyman, who is gay, said it’s hard to predict how Romney will deal with gay issues if he’s elected president.
“I think he would be perfectly comfortable in supporting civil rights for gays,” he said. “But I don’t’ think he would do anything to hurt him politically. I think he would be somewhat better than the others, but he’s not going to do anything to upset his base.”
In his election night statement, Cooper of Log Cabin Republicans cautioned Romney and the other GOP presidential candidates that adopting a “big tent” policy inclusive of gays would be the best tactic for the Republican presidential nominee to defeat Obama in November.
“Our local chapter leaders report that, like Florida voters overall, Log Cabin members in the Sunshine State were drawn to Romney’s business sense and clear plan to return America to prosperity through a strong private sector,” Cooper said.
“Still, there remain serious reservations about recent statements by Romney to so-called ‘pro-family’ groups,” Cooper said. “The real question now is whether Romney can win a majority of Americans, including younger voters, independents and disaffected Democrats,” he said. “Log Cabin Republicans are looking for a candidate who can rebuild the big tent, unite our party and claim a mandate to restore liberty and fiscal responsibility to the United States. Whether that candidate is Romney remains to be seen.”
Jerame Davis, executive director of National Stonewall Democrats, an LGBT group that is backing Obama, said Romney’s win in the Florida primary was due to his ability to “outspend and throw more mud than all of his opponents combined.”
He called Romney “a very unpopular frontrunner” whose support is not as strong as the “not-Romney” wing of the Republican Party.
Although the conservative GOProud and more moderate Log Cabin leaders often disagree over how the LGBT community should interact with the Republican Party, the two groups appeared to be in agreement this week over how to secure LGBT votes for Romney if he wins the nomination for president.
Both LaSalvia and Log Cabin members in Florida said they would stress that LGBT people, like all other voters, care about issues beyond gay rights. While Romney may not be as supportive or outspoken on LGBT issues as Obama, they said they will stress that Romney’s economic policies would help gays where it counts the most, “in their wallets and pocketbooks,” as Log Cabin’s Tampa chapter president Jim Pease said.
“So why do I think gays will do well under Romney?” asked gay Republican activist Jim Driscoll, a former Bush administration appointee to the Presidential Advisory Council on HIV/AIDS. “Romney’s opposition to discrimination against gays in jobs, etc., is genuine. He is not uncomfortable with gay people.”
Gay Democrats argue that unlike Obama, Romney hasn’t taken a position on whether he would support and sign the Employment Non-Discrimination, or ENDA, which would ban job discrimination based on sexual orientation and gender identity.
Attempts by the Blade this week to reach a Romney campaign spokesperson to determine Romney’s position on ENDA and other pending LGBT-related bills in Congress were unsuccessful.
LaSalvia notes that Obama has said he doesn’t support same-sex marriage. Gay Democrats respond by saying Obama has supported virtually all other items on the LGBT rights agenda, including repeal of the Defense of Marriage Act, which bans the federal government from recognizing same-sex marriages performed in states that have legalized them.
In what will likely emerge as the gay Republicans’ key talking point in the fall general election, LaSalvia said gays are not “one-issue” voters.
“Something I say a lot, is especially true when contrasting Obama’s policies with any of the Republican candidates, is that I believe that free market solutions benefit all Americans, but especially gay Americans,” he said.
“Whether it’s Social Security reform that includes private inheritable accounts, free market health care reform that would allow same-sex partners to go on the open market and purchase family plans, or tax reform to make the tax code simpler and fairer, Romney and the other Republican candidates are offering solutions to problems facing all of us that are far better for our country than Obama’s failed policies,” LaSalvia said.
Davis from National Stonewall Democrats said most LGBT voters will dismiss such arguments as “ridiculous.” He said NSD and the Democratic Party has and will continue to show that Obama comes out far ahead on LGBT and non-LGBT issues.
Davis said both Log Cabin and GOProud were downplaying what he called Romney’s most anti-gay stand – his agreement to sign a pledge issued by the anti-gay National Organization for Marriage to support a U.S. constitutional amendment to ban same-sex marriage.
“It’s the height of hypocrisy” that gay Republicans would attempt to excuse Romney’s support for the NOM pledge, Davis said.
“They should be ashamed for excusing any of these GOP swindlers for pandering to these regressive demagogues who seek to not only take away our rights, but persecute us back into the closet,” he said.
A random, unscientific sample of interviews with 14 gay men at Fort Lauderdale’s gay beach on Tuesday appeared to confirm the longstanding leanings of that city’s LGBT community. All 14 said they strongly support the re-election of Barack Obama and would be unlikely to vote for any Republican.
“As a gay man, I won’t vote for any Republican, said Al Adamczyk, a longtime Fort Lauderdale resident. I’m gay and I’m proud of it. Gay Republicans are idiots.”
Daniel Jeffers, a gay Air Force veteran who just moved to Fort Lauderdale with his partner, Jerry Finster, said the two believe Obama has been good on both gay and non-gay issues and would never consider voting for a Republican candidate for president.
“Some gays want him to do more,” said Finster of Obama. “He is doing everything possible. I think independents will vote for him. The Republicans are a joke. Out of a scale of five stars, I have six stars for Obama.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Looking back at the 10 biggest A&E stories of 2025
Kazakh president signs anti-LGBTQ propaganda bill
Top 10 LGBTQ local news stories of 2025
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
